Paperpal Prime Logo

Saudi Pharmaceutical Journal : Impact Factor & More

eISSN: 2213-7475pISSN: 1319-0164
JournalOpen Access

Key Metrics

CiteScore
6.8
Impact Factor
< 5
SJR
Q2Pharmacology
SNIP
1.53
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Saudi Pharmaceutical Journal

Saudi Pharmaceutical Journal Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher ELSEVIER
Language English
Frequency Bi-monthly
Article Processing ChargesUSD 1450
Publication Time12
Editorial Review ProcessDouble anonymous peer review
General Details
LanguageEnglish
Society/Institute/SponsorKing Saud University
FrequencyBi-monthly
Publication Start Year1993
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 12
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessDouble anonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC BY-NC-ND
OA statementVisit website
View less

Planning to publish in Saudi Pharmaceutical Journal ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Saudi Pharmaceutical Journal

Formononetin attenuates glucocorticoid-induced osteoporosis via multiple osteoimmunological pathways: evidence from zebrafish and network pharmacology
  • 1 Aug 2026
  • Saudi Pharmaceutical Journal : SPJ
Melittin attenuates imiquimod-induced psoriatic dermatitis in mice: a role for autophagy activation via PI3K/Akt/mTOR pathway suppression
  • 1 Aug 2026
  • Saudi Pharmaceutical Journal : SPJ
A real-world, bottom-up cost of illness analysis of type 2 diabetes mellitus from a tertiary hospital in Saudi Arabia
  • 1 Aug 2026
  • Saudi Pharmaceutical Journal : SPJ
Therapeutic potential of phytochemical compounds in cardiovascular disease: a comprehensive review
  • 1 Aug 2026
  • Saudi Pharmaceutical Journal : SPJ
Co-amorphization for solubility and dissolution rate improvement: the case of low-crystallization-tendency drugs
  • 30 Jul 2026
  • Saudi Pharmaceutical Journal : SPJ
Adherence to evidence-based guidelines for the management of candiduria in a tertiary care center in Riyadh: A retrospective cross-sectional study
  • 28 Jul 2026
  • Saudi Pharmaceutical Journal : SPJ
Formononetin attenuates glucocorticoid-induced osteoporosis via multiple osteoimmunological pathways: evidence from zebrafish and network pharmacology
  • 1 Aug 2026
  • Saudi Pharmaceutical Journal : SPJ
Melittin attenuates imiquimod-induced psoriatic dermatitis in mice: a role for autophagy activation via PI3K/Akt/mTOR pathway suppression
  • 1 Aug 2026
  • Saudi Pharmaceutical Journal : SPJ
A real-world, bottom-up cost of illness analysis of type 2 diabetes mellitus from a tertiary hospital in Saudi Arabia
  • 1 Aug 2026
  • Saudi Pharmaceutical Journal : SPJ
Therapeutic potential of phytochemical compounds in cardiovascular disease: a comprehensive review
  • 1 Aug 2026
  • Saudi Pharmaceutical Journal : SPJ
Co-amorphization for solubility and dissolution rate improvement: the case of low-crystallization-tendency drugs
  • 30 Jul 2026
  • Saudi Pharmaceutical Journal : SPJ
Adherence to evidence-based guidelines for the management of candiduria in a tertiary care center in Riyadh: A retrospective cross-sectional study
  • 28 Jul 2026
  • Saudi Pharmaceutical Journal : SPJ

FAQs on Saudi Pharmaceutical Journal